Brain stent blood thinner study pulled before it began

NCT ID NCT06857045

Terminated Disease control Sponsor: Sino Medical Sciences Technology Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study planned to compare taking blood thinners for 3 months versus 6 months after placing a special drug-coated stent in a narrowed brain artery. The goal was to see if the shorter treatment was just as good at preventing strokes and bleeding. However, the trial was withdrawn before any patients were enrolled, so no conclusions can be drawn.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dual antiplatelet therapy (blood thinners)
What this could lead to: If successful, this could show that a shorter course of blood thinners after brain stenting is as safe and effective as a longer course, reducing bleeding risk.
What could go wrong: The trial was withdrawn before any participants were enrolled, so no data was collected. It is unknown whether the shorter treatment would have been safe or effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG-ELUTING STENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral artery stenosis intracranial arterial disease intracranial arteriosclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRUG-ELUTING STENTS INTRACRANIAL ARTERIOSCLEROSIS INTRACRANIAL ARTERY STENOSIS

Contacts and locations

Locations

The Fourth Affiliated Hospital of China Medical University

Ha’erbin, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.